Simeon Taylor, MD, PhD, a seasoned pharmaceutical executive who has served in senior positions with Eli Lilly and Bristol-Meyers Squibb, has joined the University of Maryland, Baltimore (UMB) as industry liaison with its Center for Clinical Trials and Corporate Contracts (CCT).
In his new role for CCT, he will assist faculty in developing research strategies that will maximize corporate partnering and funding opportunities, and the possible creation of valuable intellectual property. CCT is part of the University's Office of Research and Development, and the part-time consultancy is funded in keeping with the University's 2011-2016 Strategic Plan